Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Riley Phillips

Physician Assistant Hattiesburg, MS Physician Assistant

NPI 1073079125 CMS profile 11149473

415 S 28Th Ave, Ste B, Hattiesburg, MS 39401

Open in the dashboard

General payments

$570

18 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Riley Phillips of Hattiesburg, MS is reported in the CMS Open Payments database as having received $570 across 18 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 58th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $35 1
2023 General $19 1
2022 General $412 11
2021 General $104 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Riley Phillips
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Riley Phillips were reported at $35. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Riley Phillips Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $104 $132 $37–$438 $132
2022 $412 $155 $48–$522 $149
2023 $19 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $35 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medical Device Business Services, Inc. $137 1 payment
  2. Intuitive Surgical, Inc. $87 1 payment
  3. Ethicon US, LLC $70 2 payments
  4. Baxter Healthcare $53 2 payments
  5. Allergan Inc. $42 2 payments
  6. Takeda Pharmaceuticals U.S.A., Inc. $40 2 payments
  7. Integra LifeSciences Corporation $31 2 payments
  8. Cumberland Pharmaceuticals, Inc. $29 1 payment
  9. Teleflex LLC $20 1 payment
  10. Myriad Genetic Laboratories, Inc. $19 1 payment
  11. Other $43 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $433 17 payments
  2. Education $137 1 payment
Products named General payments · program years 2021–2025
  1. Da Vinci Surgical System $87 1 payment
  2. DERMABOND PRINEO $48 1 payment
  3. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $42 2 payments
  4. GATTEX $40 2 payments
  5. TISSEEL $35 1 payment
  6. SURGIMEND $31 2 payments
  7. CALDOLOR $29 1 payment
  8. Harmonic $22 1 payment
  9. CONTOUR $22 1 payment
  10. WECK EFx Shield Port Site Closure System $20 1 payment
  11. Other $79 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

1,018

Median for Physician Assistant: 241

Drug cost

$6,127

Median for Physician Assistant: $4,110

Branded share of claims

2.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 243 $1,760
Methylprednisolone Generic 235 $1,438
Diclofenac Sodium Generic 90 $982
Pregabalin Generic 40 $519
Meloxicam Generic 173 $402
Ketorolac Tromethamine Generic 40 $352
Tizanidine Hcl Generic 83 $242
Tramadol Hcl Generic 52 $191
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 22 $138
Cyclobenzaprine Hcl Generic 26 $97

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$70,706

Medicare's payments for the services billed

Medicare patients

478

Average age 73

Services billed

1,365

283 women, 195 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 36%
Diabetes 31%
Depression 26%
Chronic kidney disease 19%
Osteoporosis 15%
COPD 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

18 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record